|
Agilon Health, Inc. (AGL) Évaluation DCF |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
agilon health, inc. (AGL) Bundle
Gardez un aperçu de votre Agilon Health, Inc. (AGL) Analyse d'évaluation à l'aide de notre calculatrice sophistiquée DCF! Ce modèle Excel est préchargé avec des données réelles (AGL), vous permettant d'ajuster les prévisions et les hypothèses pour déterminer avec précision la valeur intrinsèque d'Agilon Health, inc.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,218.3 | 1,833.6 | 2,708.2 | 4,316.4 | 6,060.5 | 9,060.3 | 13,544.9 | 20,249.3 | 30,272.1 | 45,255.9 |
| Revenue Growth, % | 0 | 50.5 | 47.7 | 59.38 | 40.41 | 49.5 | 49.5 | 49.5 | 49.5 | 49.5 |
| EBITDA | -40.1 | -383.8 | -72.4 | -167.6 | -218.2 | -623.0 | -931.4 | -1,392.4 | -2,081.6 | -3,111.9 |
| EBITDA, % | -3.29 | -20.93 | -2.67 | -3.88 | -3.6 | -6.88 | -6.88 | -6.88 | -6.88 | -6.88 |
| Depreciation | 14.1 | 14.7 | 13.8 | 20.2 | 24.5 | 60.5 | 90.4 | 135.1 | 202.0 | 302.0 |
| Depreciation, % | 1.16 | 0.80008 | 0.50853 | 0.46708 | 0.40364 | 0.66732 | 0.66732 | 0.66732 | 0.66732 | 0.66732 |
| EBIT | -54.2 | -398.5 | -86.2 | -187.8 | -242.6 | -683.5 | -1,021.8 | -1,527.5 | -2,283.6 | -3,413.9 |
| EBIT, % | -4.45 | -21.73 | -3.18 | -4.35 | -4 | -7.54 | -7.54 | -7.54 | -7.54 | -7.54 |
| Total Cash | 106.8 | 1,040.0 | 909.0 | 488.3 | 400.0 | 2,119.5 | 3,168.6 | 4,736.9 | 7,081.5 | 10,586.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 144.6 | 293.4 | 492.4 | 942.5 | 1,017.0 | 1,534.2 | 2,293.5 | 3,428.7 | 5,125.9 | 7,663.0 |
| Account Receivables, % | 11.86 | 16 | 18.18 | 21.83 | 16.78 | 16.93 | 16.93 | 16.93 | 16.93 | 16.93 |
| Inventories | .0 | .0 | 10.6 | .0 | .0 | 7.1 | 10.6 | 15.9 | 23.7 | 35.5 |
| Inventories, % | 0.0000000821 | 0.0000000545 | 0.39177 | 0 | 0 | 0.07835434 | 0.07835434 | 0.07835434 | 0.07835434 | 0.07835434 |
| Accounts Payable | 256.7 | 109.6 | 174.0 | 968.1 | 1,152.0 | 1,357.5 | 2,029.4 | 3,033.8 | 4,535.5 | 6,780.5 |
| Accounts Payable, % | 21.07 | 5.98 | 6.42 | 22.43 | 19.01 | 14.98 | 14.98 | 14.98 | 14.98 | 14.98 |
| Capital Expenditure | -2.4 | -13.4 | -32.7 | -30.8 | -13.3 | -55.5 | -83.0 | -124.1 | -185.5 | -277.3 |
| Capital Expenditure, % | -0.19289 | -0.73224 | -1.21 | -0.71391 | -0.21864 | -0.61274 | -0.61274 | -0.61274 | -0.61274 | -0.61274 |
| Tax Rate, % | -4.53 | -4.53 | -4.53 | -4.53 | -4.53 | -4.53 | -4.53 | -4.53 | -4.53 | -4.53 |
| EBITAT | -55.0 | -399.3 | -87.1 | -253.6 | -253.6 | -683.5 | -1,021.8 | -1,527.5 | -2,283.6 | -3,413.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 69.0 | -694.0 | -251.3 | 90.3 | -133.1 | -997.3 | -1,105.3 | -1,652.5 | -2,470.4 | -3,693.1 |
| WACC, % | 6.14 | 6.14 | 6.14 | 6.14 | 6.14 | 6.14 | 6.14 | 6.14 | 6.14 | 6.14 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -7,991.6 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | -3,841 | |||||||||
| Terminal Value | -179,743 | |||||||||
| Present Terminal Value | -133,450 | |||||||||
| Enterprise Value | -141,442 | |||||||||
| Net Debt | -147 | |||||||||
| Equity Value | -141,295 | |||||||||
| Diluted Shares Outstanding, MM | 411 | |||||||||
| Equity Value Per Share | -343.81 |
What You Will Get
- Real AGL Financial Data: Pre-filled with agilon health, inc.'s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See agilon health, inc.'s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for agilon health, inc. (AGL).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to agilon health, inc. (AGL).
- Customizable Forecast Assumptions: Update growth projections, capital expenditures, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to agilon health, inc. (AGL).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.
How It Works
- Download the Template: Gain immediate access to the Excel-based AGL DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates agilon health, inc.'s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial decisions.
Why Choose This Calculator for Agilon Health, Inc. (AGL)?
- Reliable Data: Current Agilon financials provide trustworthy valuation insights.
- Flexible Options: Modify essential factors such as growth projections, WACC, and tax rates to fit your analysis.
- Efficiency Boost: Built-in calculations save you the effort of starting from the ground up.
- Expert-Quality Tool: Tailored for investors, analysts, and healthcare consultants.
- Easy to Use: User-friendly design and clear instructions ensure accessibility for all skill levels.
Who Should Use Agilon Health, Inc. (AGL)?
- Healthcare Investors: Make informed investment choices leveraging a comprehensive analysis of the healthcare sector.
- Healthcare Analysts: Streamline your research process with ready-to-use financial models tailored for the health industry.
- Consultants: Effortlessly modify presentations or reports for clients in the healthcare space.
- Health Policy Enthusiasts: Expand your knowledge of healthcare systems and their financial implications through real-life case studies.
- Educators and Students: Utilize this resource as a hands-on educational tool in healthcare finance courses.
What the Template Contains for Agilon Health, Inc. (AGL)
- Comprehensive DCF Model: Editable template featuring thorough valuation calculations tailored for Agilon Health.
- Real-World Data: Agilon Health’s historical and projected financials preloaded for detailed analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis focusing on profitability, efficiency, and leverage specific to Agilon Health.
- Dashboard with Visual Outputs: Interactive charts and tables providing clear, actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.